Drs. Josien Terwisscha Scheltinga

Gynaecologist

Drs. Josien Terwisscha Scheltinga

Gynaecologist
99909475501
Short Waiting Time

Call us today to get appointment from this expert within short waiting times.

Zero Co-Payment!

You will only be responsible for your own risk, with no additional co-payment required.

I have been working as a gynaecologist for almost ten years with great pleasure. I enjoy the work as it is a broad field of expertise. I can help women with almost all gynaecologic complaince, for instance menstrual bleeding disorders. These disorders are benign, but can have a huge impact on your life. It is good to look at the reason for this en discuss together what are the best treatment options. My goal is to listen good to everybody and make sure that the treatment is adequate; this can be conservative (e.g. medication) or operative. 

Specialization/areas of interest 

Benign gynaecology, minimal invasive surgery, fibroid/bleeding disorders, psychosocial gynaecology

Languages 

Dutch, English

Work experience 

• 2024 Gynaecologist Gelre hospital, Apeldoorn/Zutphen
• 2022 – 2023 Gynaecologist Amphia hospital, Breda
• 2017 – 2022 Gynaecologist Rotterdam, Maastad en Ikazia hospital, Rotterdam
• 2015 – 2017 Gynaecologist Isala, Zwolle

Education 

• 2010-2015 Resident gynaecologist in RadboudUMC in Nijmegen, CWZ Nijmegen.
• 2001-2008 Medical Free University 

Publications 

• Het herkennen en behandelen van premenstruele stemmingsklachten JA. Terwisscha van Scheltinga, Marlous F. Kortekaas, Afke F. Terwisscha van Scheltinga
2024 Huisarts en Wetenschap Uitgave 7-8/2024
• Second trimester maternal tetanus, diphtheria and acellular pertussis immunisation and maternal vaccine-induced antibodies in preterm and full-term infants 
MM Immink, MN Bekker, HE de Melker et al. G den Hartog, NY Rots, PGM van Gageldonk, F Groenendaal, EAM Sanders, NAT van der Maas On behalf of a collaborative group of local principal investigators
2023 Vaccine 
• Het herkennen en behandelen van premenstruele stemmingsklachten. A.F. Terwisscha van Scheltinga, J.A. Terwisscha van Scheltinga
Tijdschr Psychiatr. 2023;65(1):40-45
• Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M Trial): a double-blind placebo-controlled randomised trial. Charlotte Hamel, M.D.; Sjors Coppus, et al. EClinicalMedicine, 2021 Jan 6;32:100716. eCollection 2021 Feb. 
• De Tarlovse cyste. drs. T. Heijink, drs. J.A. Terwisscha van Scheltinga en dr. C.A. van Donselaar. 
Nederlands Tijdschrift voor Obstetrie en Gynaecologie 2019:132: 87-89
• Persisterend verhoogd humaan choriongonadotrofine (HCG) bij een postmenopauzale vrouw: veel onrust, veel diagnostiek, weinig aan de hand? C.C. Hamel, J.A. Terwisscha van Scheltinga, J.M.W. van den Ouweland, A.M.H.W. Franssen Nederlands Tijdschrift voor Obstetrie en Gynaecologie. 2016;6;290-293
• Differentiating between gestational and chronic hypertension; an explorative study. Terwisscha van Scheltinga JA, Krabbendam I, Spaanderman ME. 
Acta Obstet Gynecol Scand. 2013 Mar;92(3):312-7.
• Verkleving van de kleine schaamlippen. J.A. Terwisscha van Scheltinga, P. de Winter, I. van Wijk, 
Tijdschrift voor Kindergeneeskunde 2008, 76, 5: 238-241